Squarepoint Ops LLC Amicus Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 664,092 shares of FOLD stock, worth $6.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

664,092

Previous 650,555 2.08%

Holding current value

$6.5 Million

Previous $6.45 Million 9.9%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $129,278 - $163,662	13,537 Added 2.08%	664,092 $7.09 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $3.61 Million - $4.69 Million	399,449 Added 159.08%	650,555 $6.45 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $2.87 Million - $3.58 Million	251,106 New	251,106 $2.96 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $53,449 - $66,313	4,986 Added 40.42%	17,321 $217,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $134,574 - $167,015	12,335 New	12,335 $136,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $77,875 - $139,000	12,500 New	12,500 $134,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $454,263 - $575,461	-46,259 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $130,750 - $177,126	14,960 Added 47.8%	46,259 $442,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $4.36 Million - $5.36 Million	-500,312 Reduced 94.11%	31,299 $302,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $4.89 Million - $12.7 Million	531,611 New	531,611 $5.25 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $999,363 - $1.77 Million	-112,795 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $747,830 - $1.26 Million	112,795 New	112,795 $1.04 Million
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $1.08 Million - $1.55 Million	-143,942 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $166,759 - $275,507	-20,793 Reduced 12.62%	143,942 $1.15 Million
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $1.29 Million - $1.69 Million	-117,370 Reduced 41.61%	164,735 $2.06 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $2.5 Million - $3.46 Million	248,829 Added 747.77%	282,105 $3.84 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $872,559 - $1.4 Million	-104,124 Reduced 75.78%	33,276 $319,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $597,168 - $851,479	51,480 Added 59.92%	137,400 $1.66 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $607,905 - $791,249	-46,299 Reduced 35.02%	85,920 $1.34 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.05 Million - $1.31 Million	76,478 Added 137.2%	132,219 $1.99 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $433,959 - $563,349	34,689 Added 164.78%	55,741 $802,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $247,150 - $332,200	21,052	21,052 $317,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Amicus Therapeutics, Inc. Transaction History